{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-008878","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.514723+00:00","generated_at":"2026-05-22T14:26:34.669752+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mangoceuticals settles lawsuit with 62,500 shares, gets $100k loan from CEO trust at 18%","bullets":["Entered settlement with 1800 Diagonal Lending, issuing 62,500 restricted shares to dismiss lawsuit with prejudice (May 5, 2025).","Borrowed $100,000 from The Tiger Cub Trust (CEO-controlled) via 18% promissory note maturing May 2, 2026.","Two Series B Preferred conversions: 100 shares for 73,333 common (Apr 28) and 300 shares for 220,000 common (May 1).","Outstanding common shares now 11,034,023 after settlement and conversion issuances."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-008878","json":"https://secwatch.observer/filing/0001641172-25-008878.json","markdown":"https://secwatch.observer/filing/0001641172-25-008878.md","text":"https://secwatch.observer/filing/0001641172-25-008878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/0001641172-25-008878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000164117225008878/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T14:26:34.669752+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}